These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35311518)

  • 1. CRISPR Inhibition of Essential Peptidoglycan Biosynthesis Genes in Mycobacterium abscessus and Its Impact on β-Lactam Susceptibility.
    Kurepina N; Chen L; Composto K; Rifat D; Nuermberger EL; Kreiswirth BN
    Antimicrob Agents Chemother; 2022 Apr; 66(4):e0009322. PubMed ID: 35311518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of β-lactamase production and β-lactam instability on MIC testing results for Mycobacterium abscessus.
    Rominski A; Schulthess B; Müller DM; Keller PM; Sander P
    J Antimicrob Chemother; 2017 Nov; 72(11):3070-3078. PubMed ID: 28961987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic Interactions of Indole-2-Carboxamides and β-Lactam Antibiotics against Mycobacterium abscessus.
    Raynaud C; Daher W; Roquet-Banères F; Johansen MD; Stec J; Onajole OK; Ordway D; Kozikowski AP; Kremer L
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32041716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "One-Two Punch": Synergistic ß-Lactam Combinations for Mycobacterium abscessus and Target Redundancy in the Inhibition of Peptidoglycan Synthesis Enzymes.
    Nguyen DC; Dousa KM; Kurz SG; Brown ST; Drusano G; Holland SM; Kreiswirth BN; Boom WH; Daley CL; Bonomo RA
    Clin Infect Dis; 2021 Oct; 73(8):1532-1536. PubMed ID: 34113990
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Chen L; Shashkina E; Kurepina N; Calado Nogueira de Moura V; Daley CL; Kreiswirth BN
    Antimicrob Agents Chemother; 2024 May; 68(5):e0017424. PubMed ID: 38557171
    [No Abstract]   [Full Text] [Related]  

  • 6. Select β-Lactam Combinations Exhibit Synergy against
    Story-Roller E; Maggioncalda EC; Lamichhane G
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745389
    [No Abstract]   [Full Text] [Related]  

  • 7. Dual β-Lactam Combinations Highly Active against Mycobacterium abscessus Complex
    Pandey R; Chen L; Manca C; Jenkins S; Glaser L; Vinnard C; Stone G; Lee J; Mathema B; Nuermberger EL; Bonomo RA; Kreiswirth BN
    mBio; 2019 Feb; 10(1):. PubMed ID: 30755518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPRi-mediated characterization of novel anti-tuberculosis targets: Mycobacterial peptidoglycan modifications promote beta-lactam resistance and intracellular survival.
    Silveiro C; Marques M; Olivença F; Pires D; Mortinho D; Nunes A; Pimentel M; Anes E; Catalão MJ
    Front Cell Infect Microbiol; 2023; 13():1089911. PubMed ID: 37009497
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Kaushik A; Ammerman NC; Lee J; Martins O; Kreiswirth BN; Lamichhane G; Parrish NM; Nuermberger EL
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR Interference-Based Inhibition of MAB_0055c Expression Alters Drug Sensitivity in Mycobacterium abscessus.
    Nguyen TQ; Heo BE; Park Y; Jeon S; Choudhary A; Moon C; Jang J
    Microbiol Spectr; 2023 Jun; 11(3):e0063123. PubMed ID: 37158736
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Yamatani I; Aono A; Fujiwara K; Asami T; Kamada K; Morishige Y; Igarashi Y; Chikamatsu K; Murase Y; Yamada H; Takaki A; Komiya K; Mitarai S
    Microbiol Spectr; 2024 Jul; 12(7):e0008424. PubMed ID: 38842354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium abscessus l,d-Transpeptidases Are Susceptible to Inactivation by Carbapenems and Cephalosporins but Not Penicillins.
    Kumar P; Chauhan V; Silva JRA; Lameira J; d'Andrea FB; Li SG; Ginell SL; Freundlich JS; Alves CN; Bailey S; Cohen KA; Lamichhane G
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual β-lactam for treatment of pulmonary
    Becken B; Dousa KM; Johnson JL; Holland SM; Bonomo RA
    Antimicrob Agents Chemother; 2024 Jul; 68(7):e0031924. PubMed ID: 38757973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic Efficacy of β-Lactam Combinations against
    Story-Roller E; Maggioncalda EC; Lamichhane G
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31109979
    [No Abstract]   [Full Text] [Related]  

  • 15. Dual β-lactam therapy to improve treatment outcome in Mycobacterium abscessus disease.
    Pozuelo Torres M; van Ingen J
    Clin Microbiol Infect; 2024 Jun; 30(6):738-742. PubMed ID: 38527611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting Mycobacterium abscessus Cell Wall Synthesis: Using a Novel Diazabicyclooctane β-Lactamase Inhibitor To Augment β-Lactam Action.
    Dousa KM; Nguyen DC; Kurz SG; Taracila MA; Bethel CR; Schinabeck W; Kreiswirth BN; Brown ST; Boom WH; Hotchkiss RS; Remy KE; Jacono FJ; Daley CL; Holland SM; Miller AA; Bonomo RA
    mBio; 2022 Feb; 13(1):e0352921. PubMed ID: 35073757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bedaquiline Eliminates Bactericidal Activity of β-Lactams against Mycobacterium abscessus.
    Lindman M; Dick T
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effects of sulopenem in combination with cefuroxime or durlobactam against
    Dousa KM; Shin E; Kurz SG; Plummer M; Nantongo M; Bethel CR; Taracila MA; Nguyen DC; Kreiswith BN; Daley CL; Remy KE; Holland SM; Bonomo RA
    mBio; 2024 Jun; 15(6):e0060924. PubMed ID: 38742824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First Penicillin-Binding Protein Occupancy Patterns for 15 β-Lactams and β-Lactamase Inhibitors in Mycobacterium abscessus.
    Sayed ARM; Shah NR; Basso KB; Kamat M; Jiao Y; Moya B; Sutaria DS; Lang Y; Tao X; Liu W; Shin E; Zhou J; Werkman C; Louie A; Drusano GL; Bulitta JB
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33106266
    [No Abstract]   [Full Text] [Related]  

  • 20. Case Commentary: Dual β-lactam as part of regimen to treat
    Lippincott CK; Lamichhane G
    Antimicrob Agents Chemother; 2024 Jul; 68(7):e0058524. PubMed ID: 38837394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.